-
Mashup Score: 9Biologic Winrevair Wins FDA Approval for Treatment of PAH - 2 month(s) ago
The injectable activin signaling inhibitor is the first of this class to be approved by the FDA and is meant to be given every 3 weeks.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet
Biologic #Winrevair Wins FDA Approval for Treatment of #PAH @TCTMD @ShelleyWood2 @mmamas1973 https://t.co/pde63KLRIG